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Tayseer M. Shamaa, Toshihiro Kitajima, Tommy Ivanics, Shingo Shimada, Sirisha Yeddula,
Adhnan Mohamed, Michael Rizzari, Kelly Collins, Atsushi Yoshida, Marwan Abouljoud, and Shunji Nagai*
Division of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, Michigan

ABSTRACT
Background. Cold climate is known to affect the frequency and attributable mortality of various illnesses. This study aims to evaluate the effect of climate among regions on liver transplant
(LT) outcomes.
Methods. We analyzed data from the United Network for Organ Sharing registry for 98,517
adult patients (aged ≥ 18 years) who were listed for LT between 2010 and 2019. During this
period, 51,571 patients underwent single-organ, deceased LT. States were categorized based on
their mean winter temperature: warm states (45°F-70°F), intermediate states (30°F-45°F), and
cold states (0°F-30°F). Post-LT outcomes at 1 month, 1 year, and 3 years were compared using
Cox proportional hazard models. Ninety-day and 1-year waitlist outcomes were compared
among climate regions using Fine-Gray hazard regression model.
Results. After adjusting risks for recipient and donor characteristics, LT candidates in cold
states had a signiﬁcantly higher waitlist (90-day: subdistribution hazard ratio (HR) 1.46; 1-year:
subdistribution HR 1.41; P < .001) and posttransplant mortality (30-day: subdistribution HR
1.23; P = .009, 1-year: subdistribution HR 1.16; P = .001; 3-year: subdistribution HR 1.08;
P = .007). LT recipients in cold states had a higher proportion of deaths due to infections than
warm states (cold states: 2.3%; intermediate states: 2.1%; and warm states: 1.7%; P < .001).
Conclusions. Potential reasons include weather-related changes in the behavioral and physiological parameters of patients.

T

HE effect of climate differences in the frequency and
attributable mortality on various medical illnesses is extensively reported in the literature [1−6]. The incidence of acute
cardiovascular and cerebrovascular events such as myocardial
infarction [7], ischemic/hemorrhagic strokes [8], and pulmonary
embolism [9] are increased during cold weather compared to
warmer temperatures. The underlying pathophysiology associated with cold weather seems to result from thrombosis due to
hemoconcentration in the cold [10,11] and from other consequences of cardiovascular reﬂexes that are brieﬂy induced by
low temperatures [12−14]. In addition, the respiratory viral
infections occur at a higher frequency during winter mainly
because of outbreaks caused by inﬂuenza, respiratory syncytial
virus, and rhinovirus [15−17].
The increased mortality of respiratory and cardiovascular diseases during winter is not only limited to healthy patients [18],
but the effect is also seen in patients with end-stage renal disease
© 2022 Elsevier Inc. All rights reserved.
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and those who underwent liver or kidney transplant surgery
[19,20]. In a study by Astor et al, the number of observed deaths
in kidney transplant recipients exceeded the number expected by
8.9% in the winter. The pattern was strongest for deaths attributable to cardiovascular disease. Similarly, there was an excess of
graft failures in winter [21]. A single-center retrospective study
evaluated the outcomes of 190 consecutive liver transplant (LT)
recipients who underwent transplantation over 10 years and
reported increased frequency of deaths in the winter that was signiﬁcantly greater than all other seasons [22]. The high wintertime
mortality could not be explained by previously recognized risk
factors of poor outcomes such as such as high Model for EndStage Liver Disease (MELD) score, dialysis requirement,
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States. We hypothesized that patients who were listed and transplanted in cold states had worse outcomes than patients in
warmer states because of a higher cumulative exposure to cold
weather. This study aims to evaluate climate effects on the waitlist and posttransplant outcomes for LT candidates/recipients.
MATERIALS AND METHODS
Patient Cohort

Fig 1. Flow chart of study population at listing/transplant.
LT, liver transplant.

intraoperative large blood loss, infections, rejection, or increased
immunosuppression [22].
Several studies have demonstrated seasonal variations in outcomes in different patient populations. Still, it is unknown
whether such geographic climate differences exist for waitlist
or posttransplant outcomes among LT recipients in the United

This study uses data from the Organ Procurement and Transplantation
Network and United Network for Organ Sharing in the Standard Transplant Analysis and Research ﬁle, including de-identiﬁed waiting list
and transplant data of all LT candidates registered since October 1,
1987 in the United States. For the analysis of waitlist outcomes, adult
patients (aged ≥18 years old at listing) listed between January 1, 2010,
and December 31, 2019, were evaluated. Patients with multi-organ listing, recipients of living donor transplant, and re-listing were excluded.
For the analysis of posttransplant outcomes, adult transplant patients
(aged >18 years old at LT) between January 1, 2010, and December 31,
2019, were evaluated. Patients who received a living donor transplant,
re-transplant, and those who underwent LT combined with kidney, thoracic organs, intestine, and/or pancreas were excluded (Fig 1).
Patients were stratiﬁed based on the state they were listed/transplanted at
into 3 groups according to the mean winter temperature in those states during the months of December, January and February (Fig 2): warm states
(45°F-70°F): Alabama, California, Florida, Georgia, Hawaii, Louisiana,
Mississippi, Puerto Rico, South Carolina, Texas and Virgin Islands; intermediate states (30°F-45°F): Arizona, Arkansas, Delaware, District of
Columbia, Kansas, Kentucky, Maryland, Missouri, Nevada, New Jersey,
New Mexico, North Carolina, Oklahoma, Oregon, Tennessee, Virginia,
Washington, and West Virginia; and cold states (0°F-30°F): Alaska, Colorado, Connecticut, Illinois, Indiana, Maine, Massachusetts, Minnesota,

Fig 2. Map of state classiﬁcation
based on mean winter temperature.
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Table 1. Characteristics of the Study Population at Listing

Candidate Characteristics

Age (years), median (IQR)
Sex, n (%)
BMI (kg/m2), median (IQR)
Ethnicity, n (%)

Diabetes, n (%)
MELD score, median (IQR)
Encephalopathy grade 3-4, n (%)
Moderate ascites, n (%)
Karnofsky score, n (%)
Candidate on life support, n (%)
Candidate on dialysis, n (%)
Diagnosis, n (%)

Days on waitlist, median (IQR)
Transplant center volume, n (%)

Season at transplant, n (%)
Era, n (%)

Male
Female
White
Black
Hispanics
Asians
Others

> 30
10-30

HCV
NASH
ALD
CLD
Others
High-volume
Mid-volume
Low-volume
Warm season
Cold season
2015-2019
2010-2014

Warm States
(45°F-70°F)
(n = 37,600)

Intermediate States
(30°F-45°F)
(n = 24,901)

Cold States
(0°F -30°F)
(n = 36,016)

57.0 (50.0, 63.0)
23733 (63.1)
13867 (36.9)
28.1 (24.6, 32.3)
22642 (60.2)
2986 (7.9)
9434 (25.1)
2086 (5.5)
452 (1.2)
9705 (26.7)
17.0 (11.0, 25.0)
3304 (8.8)
9279 (24.7)
29287 (80.2)
7231 (19.8)
1986 (5.3)
2916 (7.8)
8514 (23.4)
4697 (12.9)
7497 (20.6)
1962 (5.4)
13673 (37.6)
75.0 (12.0, 250.0)
15876 (42.2)
14232 (37.9)
7492 (19.9)
22416 (59.6)
15184 (40.4)
18248 (48.5)
19352 (51.5)

57.0 (50.0, 62.0)
16060 (64.5)
8841 (35.5)
28.5 (24.9, 32.8)
19036 (76.4)
2484 (10.0)
1973 (7.9)
809 (3.2)
599 (2.4)
6177 (25.5)
17.0 (11.0, 24.0)
2053 (8.2)
5627 (22.6)
20435 (83.3)
4089 (16.7)
846 (3.4)
1272 (5.1)
5861 (24.3)
3604 (14.9)
4670 (19.4)
1721 (7.1)
8260 (34.3)
81.0 (16.0, 234.0)
9699 (39.0)
11808 (47.4)
3394 (13.6)
14862 (59.7)
10039 (40.3)
12314 (49.5)
12587 (50.5)

57.0 (50.0, 63.0)
23787 (66.0)
12229 (34.0)
28.2 (24.7, 32.6)
27494 (76.3)
2957 (8.2)
3674 (10.2)
1396 (3.9)
495 (1.4)
9087 (26.0)
16.0 (11.0, 24.0)
2735 (7.6)
8662 (24.1)
29506 (82.8)
6120 (17.2)
1436 (4.0)
1928 (5.4)
7214 (20.7)
4717 (13.5)
7795 (22.3)
2501 (7.2)
12664 (36.3)
107.0 (20.0, 303.8)
6974 (19.4)
24779 (68.8)
4263 (11.8)
21230 (58.9)
14786 (41.1)
17047 (47.3)
18969 (52.7)

P

< .001
< .001
< .001
< .001

.004
< .001
< .001
< .001
< .001
< .001
< .001
< .001

< .001
< .001

.10
< .001

ALD, alcohol related liver disease; BMI, body mass index; CLD, cholestatic liver disease; DCD, donation after cardiac death; HCV, hepatitis C virus; IQR, interquartile
range; MELD, Model for End-stage Liver Disease; NASH, nonalcoholic steatohepatitis. Bold type indicates statistically signiﬁcant differences.

Michigan, Montana, Nebraska, New York, New Hampshire, North Dakota,
Ohio, Pennsylvania, Rhode Island, South Dakota, Utah, Vermont, Wisconsin, and Wyoming. In addition, deceased LT donors were stratiﬁed similarly
based on their home states into cold, intermediate, and warm states. The
state temperatures were based on data collected for 30 years and made available by the National Oceanic and Atmospheric Administration National Climatic Data Center of the United States [23]. This study was approved for an
institutional review board waiver after review.

Analysis of Waitlist Outcomes
In adult LT candidates, 90-day and 1-year waitlist mortality and transplant
probability were compared among the state groups. Patients removed
from the waitlist because of deterioration in their medical condition (i.e.,
too sick to transplant) were considered as waitlist mortalities. We examined 2 era groups with a 5-year range: Era 1 included listings between
2010 to 2014, and Era 2 between 2015 to 2019. Eras were deﬁned according to the availability and wide-spread use of antiviral therapy for hepatitis
C virus, which was more common in Era 2 [24]. Risks were adjusted for
the following recipient characteristics at listing based on a previous methodology: age (Categories: ≤ 50, 50-59, and > 60 years); ethnicity (Categories: white, black, Hispanic, and others), body mass index (Categories:
18.5-24.9, 25.0-29.9, and ≥ 30 kg/m2); sex (Categories: male and female);

history of diabetes (Binary: yes or no); Karnofsky performance status
score (Categories: >30 and 10-30); dialysis or life support requirement
(Binary: yes and no); MELD score (Categories: 6-14, 15-25, and ≥ 26);
presence of ascites (Categories: none/mild, and moderate/severe) or
encephalopathy (Categories: none/Grade 1-2, and Grade 3-4); diagnosis
of end-stage liver disease (hepatitis C, non-alcoholic steatohepatitis, alcohol-related liver disease, cholestatic liver disease, and others); season; and
listing center transplant volume and era of listing (Eras 1-2) [25]. The seasons were stratiﬁed into either warm (April to October) or cold (November
to March). To evaluate the effects of transplant center experience on outcomes, transplant centers were classiﬁed into 3 groups: Group 1: centers
that performed 62 or more cases of LT per year during the study period
(high-volume center group); Group 2: centers that performed between 62
and 30 LT per year during the study period (mid-volume center group);
and Group 3: centers that performed less than 30 LT per year during the
study period (low-volume center group). We used the 75th percentile
value (62 transplants/year) and 50th percentile value (30 transplants/year)
of the number of LTs in each center as the threshold.

Analysis of Posttransplant Outcomes
In adult deceased LT recipients, 30-day, 1-year, and 3-year posttransplant liver graft and patient survival were compared among state groups.
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Fig 3. Comparison of 1-year waitlist outcomes between different states according to their winter temperature: cold (0°F-30°
F) and intermediate (30°F-45°F) (reference warm states (45°F70°F) for entire cohort.
Possible risk factors for posttransplant graft loss and mortality were
investigated for each state group. We examined 2 era groups with 5year range: Era 1 included patients transplanted between 2010 to 2014,
and Era 2 between 2015 to 2019. The hazards of mortality were
adjusted for the following variables based on previous methodology
[25]. Recipient variables at transplant included the following based on a
previous methodology: age (Categories: ≤ 50, 50-59, and > 60 years);
sex (Categories: male and female); ethnicity (Categories: White, Black,
Hispanic, and other); body mass index (Categories: 18.5-24.9, 25.029.9, and ≥ 30 kg/m2); MELD score (Categories: 6-14, 15-25, and ≥
26); diabetes (Binary: yes or no); Karnofsky performance status score
(Categories: >30, and 10-30); hepatocellular carcinoma (Binary: yes
and no); diagnosis of end-stage liver disease (hepatitis C, non-alcoholic
steatohepatitis, alcohol-related liver disease, cholestatic liver disease,
and others); dialysis (Binary: yes and no) or life support requirement
(Binary: yes and no); presence of ascites (Categories: none/mild, and
moderate/severe) or encephalopathy (Categories: none/Grade 1-2, and
Grade 3-4); season; transplant center volume (Categories: low-, mid-,
and high-volume centers); and Era of transplant (Eras 1-2) [25]. Donor
variables included split liver graft (Binary: yes and no); type of donation
(Categories: donation after cardiac death and donation after brain
death), organ share type (Categories: local, regional, and national); age
(continuous); sex (Categories: male and female); ethnicity (Categories:
white, black, Hispanic, and other); cold ischemia time (Categories: ≤ 8
and > 8); and cause of death (Categories: anoxia, cerebrovascular accident, and head trauma) [26].

Statistical Analysis
Data were analyzed using the median with interquartile range for continuous variables and using percentages for discrete variables. Comparisons of
continuous variables and discrete variables were performed using the

Mann-Whitney test and x2 test. Waitlist outcomes were compared by the
Gray test to estimate the cumulative incidence of competing events, including death, transplantation, removal from waitlist due to clinical improvement, and removal from the waitlist for other reasons. The Fine-Gray
proportional hazard regression for competing events was used to perform
casual evaluation of the subdistribution hazards of waitlist outcomes after
adjusting for candidate variables at listing. Patient survival and liver graft
survival rates were estimated by a Kaplan-Meier method with log-rank
tests. Casual evaluation of risk factors for posttransplant mortality and the
subdistribution hazard risk (sHR) were analyzed using Cox proportional
hazards models and compared among state groups. The hazards of patient
death were adjusted for recipient and donor variables described. P value <
.05 was considered statistically signiﬁcant. All statistical analyses were
completed using SPSS version 25 (IBM, Armonk, New York, USA) and
EZR version 1.37 (Saitama, Japan), which is a graphical user interface for
R (The R Foundation for Statistical Computing, Vienna, Austria).

RESULTS
Patient Characteristics at Listing

A total of 117,981 adult patients were registered for LT during
the study period. The following populations were excluded:
3,139 listed for a re-transplant; 2,674 received a living donor
transplant; 448 with a location of listing that is missing or outside of the United States; and 13,203 listed for LT combined
with thoracic organs, intestine, or pancreas. A total of 98,517
adult LT candidates were identiﬁed for the analysis of the waitlist outcomes: 37,600 (38.2%) patients listed in warm states;
24,901 (25.2%) listed in intermediate states; and 36,016
(36.6%) listed in cold states (Fig 1). The number of patients
listed with the diagnosis of alcohol-related liver disease was
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Table 2. Characteristics of the Study Population at Transplant

Recipient characteristics
Age (y), median (IQR)
Age (y), n (%)

Sex, n (%)
BMI (kg/m2), median (IQR)
Ethnicity, n (%)

Diabetes, n (%)
MELD score, median (IQR)
Encephalopathy grade 3-4, n (%)
Moderate ascites, n (%)
Karnofsky score, n (%)
Recipient on life support, n (%)
Recipient on dialysis, n (%)
Diagnosis, n (%)

Transplant center volume, n (%)

Season at transplant, n (%)
Era, n (%)
Donor characteristics
Age (y), median (IQR)
Sex, n (%)
BMI (kg/m2), median (IQR)
Ethnicity, n (%)

History of diabetes, n (%)
History of MI, n (%)
History of hypertension, n (%)
History of cocaine use, n (%)
History of heavy alcohol use, n (%)
History of heavy cigarette use, n (%)
Cause of death, n (%)

DCD donor, n (%)
Allocation type, n (%)

Split graft, n (%)
DRI, median (IQR)
CIT (hours), median (IQR)

< 50
50-59
≥ 60
Male
Female
White
Black
Hispanics
Asians
Others

> 30
10-30

HCV
NASH
ALD
CLD
Others
High-volume ≥ 62 Tx/year
Mid-volume 30-62 Tx/year
Low-volume < 30 Tx/year
Warm season
Cold season
2015-2019
2010-2014

Male
Female
White
Black
Hispanics
Asians
Others

Trauma
Anoxia
Cerebrovascular
Others
Local
Regional
National
Yes

Warm States
(45-70°F)
(n = 19,532)

Intermediate States
(30-45°F)
(n = 13,779)

Cold States
(0-30°F)
(n = 17,546)

58.0 (51.0, 63.0)
4326 (22.1)
7094 (36.3)
8112 (41.5)
12658 (64.8)
6874 (35.2)
28.4 (24.5, 32.5)
12115 (62.0)
1629 (8.3)
4469 (22.9)
1087 (5.6)
232 (1.2)
4877 (25.7)
22.0 (14.0, 32.0)
2253 (11.5)
6038 (30.9)
13374 (69.0)
6015 (31.0)
2251 (11.5)
2657 (13.6)
4196 (21.9)
2608 (13.6)
4055 (21.2)
1060 (5.4)
7613 (37.9)
8654 (44.3)
3753 (19.2)
7125 (36.5)
11436 (58.6)
8096 (41.4)
11522 (59.0)
8010 (41.0)

57.0 (51.0, 63.0)
3127 (22.7)
5108 (37.1)
5544 (40.2)
9232 (67.0)
4547 (33.0)
28.8 (25.3, 33.0)
10543 (76.5)
1411 (10.2)
1067 (7.7)
425 (3.1)
333 (2.4)
3359 (25.0)
21.0 (13.0, 30.0)
1582 (11.5)
3963 (28.8)
10151 (74.2)
3535 (25.8)
724 (5.3)
1176 (8.6)
3279 (24.3)
1979 (14.6)
2630 (19.5)
895 (6.5)
4996 (35.1)
5786 (42.0)
1678 (12.2)
6315 (45.8)
8164 (59.2)
5615 (40.8)
8094 (58.7)
5685 (41.3)

58.0 (51.0, 63.0)
3882 (22.1)
6231 (35.5)
7433 (42.4)
11981 (68.3)
5565 (31.7)
28.7 (25.1, 32.9)
13599 (77.5)
1398 (8.0)
1626 (9.3)
690 (3.9)
233 (1.3)
4392 (25.6)
21.0 (13.0, 31.0)
2110 (12.0)
5417 (30.9)
12329 (71.0)
5034 (29.0)
1104 (6.3)
1600 (9.1)
3562 (20.6)
2419 (14.0)
3739 (21.7)
1241 (7.1)
6585 (36.6)
3892 (22.2)
2219 (12.6)
11435 (65.2)
10367 (59.1)
7179 (40.9)
10340 (58.9)
7206 (41.1)

< .001
.005

43.0 (28.0, 55.0)
11554 (60.8)
7458 (39.2)
26.8 (23.4, 31.1)
9969 (52.4)
3924 (20.6)
3792 (19.9)
703 (3.4)
689 (3.6)
2515 (13.3)
729 (3.9)
7273 (38.5)
3224 (17.2)
2861 (15.4)
3581 (19.2)
6175 (33.2)
5438 (29.2)
6924 (37.2)
84 (0.5)
1062 (5.6)
14163 (69.1)
5620 (27.4)
713 (3.5)
168 (0.9)
1.54 (1.32, 1.84)
5.93 (4.60, 7.45)

41.0 (27.0, 54.0)
8558 (59.0)
5955 (41.0)
26.9 (23.5, 31.5)
10146 (69.9)
2702 (18.6)
1188 (8.2)
318 (2.0)
184 (1.3)
1774 (12.3)
693 (4.8)
5267 (36.5)
2784 (19.6)
2226 (15.7)
3393 (23.8)
4283 (30.3)
5281 (37.4)
4511 (31.9)
63 (0.4)
1011 (7.0)
9939 (63.8)
4770 (30.6)
872 (5.6)
153 (1.1)
1.52 (1.30, 1.83)
5.75 (4.45, 7.23)

43.0 (29.0, 55.0)
10299 (59.3)
7068 (40.7)
27.1 (23.6, 31.6)
12865 (74.1)
2647 (15.2)
1438 (8.3)
300 (1.6)
141 (0.8)
2160 (12.5)
667 (3.9)
6192 (35.9)
3795 (22.2)
2969 (17.5)
4239 (24.9)
4529 (26.5)
7202 (42.2)
5296 (31.0)
48 (0.3)
1404 (8.1)
13752 (72.9)
4336 (23.0)
778 (4.1)
308 (1.8)
1.54 (1.29, 1.84)
5.87 (4.70, 7.18)

< .001
.001

P

< .001
< .001
< .001

.48
< .001
.23
< .001
< .001
< .001
< .001

< .001

.29
.70

< .001
< .001

.012
< .001
< .001
< .001
< .001
< .001
< .001

< .001
< .001

< .001
< .001
< .001

ALD, alcoholic liver disease; BMI, body mass index; CIT, cold ischemia time; CLD, cholestatic liver disease; DCD, donation after cardiac death; DRI, donor risk index;
HCV, hepatitis C virus; IQR, interquartile range; MELD, Model for End-stage Liver Disease; MI, myocardial infarction; NASH, nonalcoholic steatohepatitis; Tx: Transplant. Bold type indicates statistically signiﬁcant differences.
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Fig 4. Comparison of Cox regression patient survival for cold
states (0°F-30°F), intermediate states (30°F-45°F), and warm
states (45°F-70°F) for entire cohort.

higher in cold states (7795 (22.3%)) compared to intermediate
(4670 (19.4%)) and warm states (7497 (20.6%)). The days on
the waitlist (cold states: 107 days; intermediate states: 81 days;
and warm states: 75 days; P < .001) were signiﬁcantly higher,
and the MELD score at listing (cold states: 16.0; intermediate
states: 17.0; and warm states 17.0; P < .001) was lower in cold
states than in other groups (Table 1). The proportion of patients
listed at high-volume transplant centers were the lowest in cold
states 6974 (19.4%) compared to intermediate 9699 (39.0%),
and warm states 15,876 (42.2%) (Table 1).

favorable features compared to the remaining states as evident
by the lower body mass index (median (interquartile range)
26.8 kg/m2 (28.0-55.0); P < .001), lower proportions of donation after circulatory death donors 1062 (5.6%; P < .001), and
lower proportions of donors with a history of heavy alcohol use
2861 (17.1%; P < .001) and heavy cigarettes use 3581 (19.2%;
P < .001) (Table 2). The proportion of LT occurring at highvolume transplant centers was signiﬁcantly higher in the warm
states group than in the intermediate and cold states respectively
(warm 44.3%, intermediate 42.0%, and cold 22.2%; P < .001).

Waitlist Outcomes Among the Climate Groups

Mortality Analysis of Adult LT Recipients According to State
Groups

Patients listed in cold states had signiﬁcantly higher risk of 90day and 1-year waitlist mortality than those listed in warm states
(90-day: sHR 1.46, 95% CI 1.21-1.77; P < .001; and 1-year:
sHR 1.41, 95% CI 1.24-1.60; P < .001). The risk of 90-day and
1-year waitlist mortality was similar between intermediate and
warm states (Fig 3). Listings in cold states were associated with
a statistically signiﬁcantly lower transplant probability than listings in intermediate states at 90 days (reference: warm states,
90 days; intermediate states: sHR 0.94, 95% CI 0.92-0.97; P <
.001; cold states: sHR 0.81, 95% CI 0.78-0.83; P < .001; see
Figure 3).
Patient Characteristics at Transplant

A total of 50,857 transplant patients were evaluated. Among
them, 19,532 (38.4%) were transplanted in warm states, 13,779
(27.1%) were transplanted in intermediate states and 17,546
(34.5%) were transplanted in cold states (Fig 1). Regarding
recipient characteristics, patients who underwent LT in warm
states were sicker compared to the remaining states with a
higher median MELD score (median (interquartile range): 22.0
(14.0-32.0); P < .001), and higher proportions of life support
requirement 2251 (11.5%; P < .001) (Table 2). Although the
donor risk index was similar between cold and warm states
(median [(interquartile range): cold 1.54 (1.29-1.84); warm
1.54 (1.32-1.84); P < .001), the donors in warm states had more

When assessing the risk of mortality according to the state temperature groups, multivariable Cox regression analysis revealed
that undergoing LT surgery in cold states was associated with
higher risk for mortality at 30-days (sHR 1.23, 95% CI 1.051.45; P = .009 (reference warm states)), 1-year (sHR 1.16, 95%
CI 1.07-1.27; P = .001 (reference warm states)) and 3-year
(sHR 1.08, 95% CI 1.03-1.17; P = .007 (reference warm
states)). Moreover, LT recipients in intermediate states had a
higher risk of mortality at 1-year (intermediate states: sHR 1.13,
95% CI 1.03-1.23; P = .01) and 3-year (intermediate states:
sHR 1.08, 95% CI 1.01-1.16; P = .03) compared to warm states
but lower than that for cold states (reference warm states) (Fig 4
and Supplemental Table 1). In terms of the causes of death,
patients in cold states had a higher proportion of deaths due to
infections (2.3%) compared to intermediate (2.1%) and warm
states (1.7%; P < .001). There was no statistically signiﬁcant
difference in the cardiovascular and cerebrovascular causes of
death for LT recipients among the temperature regions (Table 3).

Subgroup Analysis of Waitlist and Posttransplant Outcomes
in Each Center Volume Group

Transplant centers were categorized into 3 groups based on their
transplant volume. Cold states had a lower proportion of highvolume transplant centers. The interaction between center
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Table 3. Causes of Death for Liver Transplant Recipients

Cardiovascular, n (%)
Cerebrovascular, n (%)
Infection, n (%)
Others, n (%)

Warm States
(45°F-70°F)

Intermediate States
(30°F-45°F)

Cold States
(0°F-30°F)

P

430 (2.2)
80 (0.4)
332 (1.7)
1715 (8.8)

321 (2.3)
65 (0.5)
294 (2.1)
1195 (8.7)

443 (2.5)
64 (0.4)
395 (2.3)
1619 (9.2)

.45
.36
< .001
< .001

volume groups and posttransplant outcomes was examined to
address possible concerns about effects of center volume on
outcomes. There was no statistically signiﬁcant interaction
between low- or mid-volume transplant centers and cold states
for short-term and long-term patient survival (30-day, P = .34;
1-year, P = .57; and 3-year, P = .88). The signiﬁcant association
among the climate groups and waitlist and posttransplant outcomes was independent of the center volume group. To further
examine this, the waitlist and posttransplant outcomes were
evaluated within each group. Patients listed at low-volume centers in cold states had worse 90-day and 1-year waitlist mortality compared to warm states (90-day: sHR 1.58, 95% CI 1.182.01; P = .002; and 1-year: sHR 1.60, 95% CI 1.33-1.93; P <
.001) and lower transplant probability at 90-day and 1-year
compared to warm states (90-day: sHR 0.76, 95% CI 0.73-0.80;
P < .001; and 1-year: sHR 0.74, 95% CI 0.71-0.76; P < .001).
Patients listed at high-volume centers in cold states had worse
90-day waitlist mortality compared to warm states (90-day:
sHR 1.46, 95% CI 1.05-2.03; P = .023) and lower transplant
probability at 1-year compared to warm states (1-year: sHR
0.94, 95% CI 0.90-0.99; P = .010) (Supplemental Figs 1 and 2).
In terms of posttransplant outcomes, patients transplanted at
low-volume centers in cold states had a higher risk of mortality
at 1 year and 3 years compared to warm states (30-day: sHR
1.32, 95% CI 1.06-1.65; P = .012; 1-year: sHR 1.19, 95% CI
1.05-1.35; P = .008; and 3-year: sHR 1.18, 95% CI 1.01-1.23;
P = .025). Patients transplanted at high-volume centers in cold
states had similar risk of mortality at 30 days, 1 year, and 3 years
(Supplemental Fig 3).
DISCUSSION

Using 10 years of national data, we observed a signiﬁcantly
higher waitlist and posttransplant mortality risk for LT candidates
and recipients in cold states. LT patients in cold states were more
likely to be less sick at listing with lower MELD scores and were
less likely to require life support or dialysis. After adjusting risks
for those characteristics, a signiﬁcantly higher risk of waitlist and
posttransplant mortality in cold states remained observed and LT
recipients in cold states had a higher proportion of deaths due to
infections than warm states, which might have contributed to the
ﬁndings observed. There are no previous studies looking at the
relationship between climate regions and LT waitlist/posttransplant outcomes using a national database.
Several studies have evaluated the effect of weather on the
overall health and susceptibility to disease for the general population and patients with end-stage organ disease. A study by Lin
et al identiﬁed low temperature and high humidity as risk factors for acute on chronic liver failure [27]. The effect of climate

on alcohol consumption and alcohol-related liver disease in the
United States was explored in a study by Williams et al, who
showed a negative correlation between the age-standardized
prevalence of heavy drinking, liters of alcohol consumption,
and state temperatures [28]. Patients in cold states had a higher
proportion of patients with alcohol-related liver disease (22.3%;
P < .001) compared to intermediate (19.4%) and warm states
(20.6%). It has been reported that patients with alcohol-related
liver disease had better waitlist and posttransplant outcomes
compared to patients with other major liver disease etiologies
[25]. Despite this, patients transplanted in cold states had worse
posttransplant outcomes compared to warm states. Cold
weather leads to an increase in respiratory disease secondary to
cross-infection from indoor crowding, the adverse effects of
cold on the immune system’s resistance to respiratory infection,
and the fact that low temperatures improves the survival of bacteria in droplets [29]. The increase in the frequency of acute
respiratory infections in the winter predisposes patients to cardiovascular disease because infections increase the risk for arterial thrombosis through endothelial dysfunction and activation
of the inﬂammatory and coagulation system [14,30−33]. This
was reinforced by the ﬁndings in our study that LT recipients in
cold states had a higher proportion of mortality due to infections
than other regions (cold states: 2.3%, intermediate states 2.1%,
and warm states: 1.7%; P < .001). Other possible reasons for
the ﬁndings of this study would include the increased risk of
cardiovascular diseases during cold weather. Cold weather can
trigger an excess cardiac sympathetic activity, hypercoagulopathy, and excess inﬂammatory response that may have contributed to the excess of cardiovascular diseases mortality during
winter months. However, the data from our study could not support this ﬁnding as there was no statistical difference in the
cardiovascular and cerebrovascular causes of death for LT
recipients in our cohort. It is unclear the exact mechanisms
underlying these meteorologic factors; however, this can be
partly attributed to changes in temperature.
The transplant center volume is a well-known risk factor for
worse outcomes [34,35]. The effect of low-center volume on
waitlist outcomes has been demonstrated in a previous study by
Wong et al in which waitlist mortality for patients with acute
liver failure was highest at low-volume centers [36]. We noticed
a higher proportion of patients being transplanted at low-volume centers in cold states (65.2%; P < .001) compared to intermediate states (45.8%) and warm states (36.5%). While the
variation in organ acceptance practices based on the transplant
center experience at low-volume centers would have been a reason for the worse waitlist and posttransplant outcomes in cold
states, the subgroup analysis evaluating only low-volume centers showed that the waitlist mortality remained the highest in
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cold-states compared to warm states at 90 days, and patients
transplanted in cold states had higher risk for mortality compared to warm states at 30 days. These highlight the potential
effect of cold weather on outcomes in LT patients. Varying clinical practice patterns between sites, socioeconomic status, and
patient-level characteristics such as the presence and severity of
comorbidities, all of which may have modiﬁed the association
between climate and outcomes. The effect of the weather may
be an important factor to consider as transplant centers undergo
regular review process to ensure high-quality care if their outcomes are signiﬁcantly worse than expected.
Relevant strengths of this study include a large number of LT
patients assessed using the national transplant registry over
10 years. There are several limitations to our study that deserve to
be acknowledged. The advantage of using a large registry database is at the expense of a lack of granularity in the collected data.
The exact causes of death and graft failure cannot be veriﬁed or
entirely captured during the follow-up period. We could not
obtain information about the recipient’s cardiovascular disease
prior to transplant as this is not recorded by the United Network
for Organ Sharing registry. Data linkage of registry data to other
databases can allow the collection of additional information, such
as the type and nature of cause-speciﬁc mortality, which could
improve the ﬁndings of our study. In addition, validating this
association in other population registry cohorts outside of the
United States may provide greater conﬁdence in the robustness of
the estimates between seasonality and outcomes.
CONCLUSIONS

This study revealed that patients in cold states had worse waitlist and posttransplant outcomes than other climate regions after
adjusting risks for the recipient, donor factors and center volume. Our results highlight the need for further studies to understand better the pathologic mechanisms resulting in worse
waitlist and posttransplant outcomes in colder states. These
ﬁndings would have important implications for research and
clinical care, including the need for closer monitoring of LT
patients in cold areas, especially for risk of infection.
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